Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB known ✓ | P27338 | 2/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7770837 | 0.98 | PAOX (0.38) | PAOXMEN1BLMPMP22KMT2A | |
| SCHEMBL50166 | 0.98 | — | — | |
| Ammonia Solution, Strong SCHEMBL27914279 | 0.95 | PAOX (0.39) | PAOXMEN1BLMPMP22KMT2A | |
| Trimethylammonium SCHEMBL27672173 | 0.94 | PAOX (0.35) | PAOXMEN1BLMPMP22KMT2A | |
| Chloromethane SCHEMBL1803774 | 0.93 | PAOX (0.38) | PAOXMEN1BLMPMP22KMT2A | |
| Trimethylammonium SCHEMBL27741449 | 0.91 | PAOX (0.36) | PAOXMEN1BLMPMP22KMT2A | |
| Acetic Acid SCHEMBL7770839 | 0.91 | TGFBR1 (0.37) | PAOXMEN1BLMPMP22KMT2A | |
| Phosphoric Acid SCHEMBL9950456 | 0.90 | PAOX (0.35) | PAOXMEN1BLMPMP22KMT2A | |
| Hydrochloric Acid SCHEMBL82715 | 0.87 | PAOX (0.50) | PAOXPMP22TGFBR1KDM4EMAPK1 | |
| Hydrochloric Acid SCHEMBL28412040 | 0.87 | PAOX (0.50) | PAOXPMP22TGFBR1KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595396-B2 | Acid resistant filter media | ENTEGRIS, INC. (US) | 2026-04-07 | — | — | US | claimed |
| CN-120114407-A | Composite magnetic photo-thermal microsphere, preparation method thereof, embolic preparation and application | 南方科技大学 | 2025-06-10 | — | — | CN | claimed |
| EP-4314154-B1 | WATER-SOLUBLE POLYMER TO PREVENT NON-SPECIFIC ADSORPTION | N LAB TECH CENTER PTE LTD (SG) | 2025-04-23 | — | — | EP | claimed |
| EP-3463631-B1 | COATED POROUS POLYMERIC MEMBRANES | ENTEGRIS INC (US) | 2024-09-04 | — | — | EP | claimed |
| US-20240182698-A1 | WATER-SOLUBLE POLYMER TO PREVENT NON-SPECIFIC ADSORPTION | N-LAB TECHNOLOGY CENTER PTE. LTD. (SG) | 2024-06-06 | — | — | US | claimed |
| CN-118125951-A | Sulfonyl zwitterionic polymer with antibacterial function, and preparation method and application thereof | 河南科技大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117860433-A | Intraocular lens conveying device and preparation method thereof | 上海新耀湃科医疗科技股份有限公司 | 2024-04-12 | — | — | CN | claimed |
| EP-4314154-A1 | WATER-SOLUBLE POLYMER TO PREVENT NON-SPECIFIC ADSORPTION | N-Lab Technology Center Pte. Ltd. (SG) | 2024-02-07 | — | — | EP | claimed |
| CN-114230678-B | Photocrosslinked hydrogel embolism system for intravascular treatment and application method | 珠海通桥医疗科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-11731085-B2 | Coated porous polymeric membranes | ENTEGRIS, INC. (US) | 2023-08-22 | — | — | US | claimed |
| US-20150206793-A1 | POLYMER GRAFTING FOR ENHANCED DIELECTRIC AND INTERCONNECT MATERIAL ADHESION | INTEL CORPORATION | 2015-07-23 | — | — | US | claimed |
| CN-102643218-B | Fluorescent material and preparation method and application thereof | UNIV HUAZHONG SCIENCE TECH | 2014-06-18 | — | — | CN | claimed |
| US-20100051461-A1 | Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis | Life Technologies Corporation (US) | 2010-03-04 | — | — | US | claimed |
| EP-2053067-A1 | Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis | Applied Biosystems Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| EP-1636279-B1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS (US) | 2009-02-18 | — | — | EP | claimed |
| US-20060181587-A1 | Ink set and media for ink-jet printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2006-08-17 | — | — | US | claimed |
| EP-1636279-A1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | Applera Corporation (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | APPLIED BIOSYSTEMS, LLC | 2005-02-03 | — | — | US | claimed |
| WO-2004104054-A1 | POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-12-02 | — | — | WO | claimed |
| US-20030152961-A1 | Polyfunctional support material for complex nucleic acid analysis | BENDZKO PETER (DE) | 2003-08-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595396-B2 | Acid resistant filter media | SDC2, F7, SDC1 | MAOB 3116/4885PAOX 1761/4885MEN1 1995/4885 |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | POLI, PCNA, POLL | MAOB 3227/4885PAOX 1846/4885MEN1 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.